Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Book

Beta-Lactamase Inhibitors

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.
.
Affiliations
Free Books & Documents
Book

Beta-Lactamase Inhibitors

Niloufar R. Khanna et al.
Free Books & Documents

Excerpt

Beta-lactamase inhibitors are co-administered with beta-lactam antimicrobials to prevent antimicrobial resistance. They do this by inhibiting serine beta-lactamases, enzymes that inactivate the beta-lactam ring which are a common chemical structure to all beta-lactam antimicrobials. This activity outlines the different types of beta-lactamase inhibitors. It discusses the pharmacological properties of beta-lactamase inhibitors, their medical uses, administration methods, side effects, and other properties. It also highlights providers' critical role in correctly administering beta-lactamase inhibitors in combination with beta-lactam antimicrobials and counseling patients regarding medication adherence.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Niloufar Khanna declares no relevant financial relationships with ineligible companies.

Disclosure: Valerie Gerriets declares no relevant financial relationships with ineligible companies.

References

    1. Tamma PD, Villegas MV. Use of β-Lactam/β-Lactamase Inhibitors for Extended-Spectrum-β-Lactamase Infections: Defining the Right Patient Population. Antimicrob Agents Chemother. 2017 Aug;61(8) - PMC - PubMed
    1. Pandey N, Cascella M. StatPearls [Internet] StatPearls Publishing; Treasure Island (FL): 2023. Jun 4, Beta-Lactam Antibiotics. - PubMed
    1. Curello J, MacDougall C. Beyond Susceptible and Resistant, Part II: Treatment of Infections Due to Gram-Negative Organisms Producing Extended-Spectrum β-Lactamases. J Pediatr Pharmacol Ther. 2014 Jul;19(3):156-64. - PMC - PubMed
    1. Shirley M. Ceftazidime-Avibactam: A Review in the Treatment of Serious Gram-Negative Bacterial Infections. Drugs. 2018 Apr;78(6):675-692. - PubMed
    1. File TM, Tan JS, Salstrom SJ, Johnson LA, Douglas GF. Timentin versus piperacillin or moxalactam in the therapy of acute bacterial infections. Antimicrob Agents Chemother. 1984 Sep;26(3):310-3. - PMC - PubMed

Publication types

LinkOut - more resources